DK1721162T3 - Fremgangsmåde til at bedömme rheumatoid arthritis ved at måle anti-CCP og serumamyloid A - Google Patents

Fremgangsmåde til at bedömme rheumatoid arthritis ved at måle anti-CCP og serumamyloid A

Info

Publication number
DK1721162T3
DK1721162T3 DK05707585T DK05707585T DK1721162T3 DK 1721162 T3 DK1721162 T3 DK 1721162T3 DK 05707585 T DK05707585 T DK 05707585T DK 05707585 T DK05707585 T DK 05707585T DK 1721162 T3 DK1721162 T3 DK 1721162T3
Authority
DK
Denmark
Prior art keywords
rheumatoid arthritis
ccp
serum amyloid
absence
measuring anti
Prior art date
Application number
DK05707585T
Other languages
Danish (da)
English (en)
Inventor
Norbert Wild
Johann Karl
Veit Peter Grunert
Werner Zolg
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK1721162T3 publication Critical patent/DK1721162T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/10Musculoskeletal or connective tissue disorders
    • G01N2800/101Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/102Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/24Immunology or allergic disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Rehabilitation Therapy (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK05707585T 2004-02-27 2005-02-23 Fremgangsmåde til at bedömme rheumatoid arthritis ved at måle anti-CCP og serumamyloid A DK1721162T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04004586 2004-02-27
PCT/EP2005/001861 WO2005085858A1 (en) 2004-02-27 2005-02-23 Method of assessing rheumatoid arthritis by measuring anti-ccp and serum amyloid a

Publications (1)

Publication Number Publication Date
DK1721162T3 true DK1721162T3 (da) 2008-12-15

Family

ID=34917159

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05707585T DK1721162T3 (da) 2004-02-27 2005-02-23 Fremgangsmåde til at bedömme rheumatoid arthritis ved at måle anti-CCP og serumamyloid A

Country Status (12)

Country Link
US (2) US7981693B2 (pt)
EP (2) EP1721162B1 (pt)
JP (1) JP4495208B2 (pt)
AT (1) ATE409314T1 (pt)
CA (1) CA2552420A1 (pt)
DE (1) DE602005009925D1 (pt)
DK (1) DK1721162T3 (pt)
ES (1) ES2314621T3 (pt)
PL (1) PL1721162T3 (pt)
PT (1) PT1721162E (pt)
SI (1) SI1721162T1 (pt)
WO (1) WO2005085858A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009138408A2 (en) * 2008-05-14 2009-11-19 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and kits for the diagnosis of rheumatoid arthritis
FI20086145A0 (fi) * 2008-12-01 2008-12-01 Kansanterveyslaitos Menetelmä autoimmuunisairauksien osoittamiseksi
EP2193790A1 (en) 2008-12-04 2010-06-09 Klinikum der Universität Regensburg IL-3 Inhibitors in use for treatment of rheumatoid arthritis in an early stage
WO2010075249A2 (en) 2008-12-22 2010-07-01 Genentech, Inc. A method for treating rheumatoid arthritis with b-cell antagonists
US10309974B2 (en) 2010-11-12 2019-06-04 Cedars-Sinai Medical Center Citrullinated proteins: a post-translated modification of myocardial proteins as marker of physiological and pathological disease
CA2817847C (en) * 2010-11-12 2018-02-13 The Johns Hopkins University Citrullinated proteins: a post-translated modification of myocardial proteins as marker of physiological and pathological disease
CN102323402A (zh) * 2011-05-30 2012-01-18 上海精臻生物科技有限公司 抗环瓜氨酸肽抗体体外检测试剂盒及制备方法
KR101793008B1 (ko) * 2014-08-18 2017-11-03 한국과학기술원 표면증강 라만 산란을 이용한 진단 플랫폼 및 이를 이용한 진단 방법
EP3256854A1 (en) 2015-02-13 2017-12-20 F. Hoffmann-La Roche AG Method of assessing rheumatoid arthritis by measuring anti-ccp and anti-pik3cd
US10429379B2 (en) 2015-05-12 2019-10-01 The General Hospital Corporation Autoantigens for diagnosis of rheumatoid arthritis
JP2018524575A (ja) 2015-06-18 2018-08-30 シーダーズ−サイナイ メディカル センター 疾患の診断におけるシトルリン化の役割
WO2017214180A1 (en) 2016-06-07 2017-12-14 The General Hospital Corporation Identification of a t cell epitope of prevotella copri that induces t cell responses in patients with rheumatoid arthritis
CN116148466B (zh) * 2023-04-23 2023-11-21 北京大学人民医院 用于类风湿关节炎诊断的多血清标志物组合

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2752842B1 (fr) 1996-08-30 1998-11-06 Biomerieux Sa Antigenes derives des filaggrines et leur utilisation pour le diagnostic de la polyarthrite rhumatoide
NL1004539C2 (nl) 1996-11-15 1998-05-20 Stichting Tech Wetenschapp Peptide afgeleid van een door auto-antilichamen van patiënten met reumatoïde artritis herkend antigeen, antilichaam daartegen en werkwijze voor het detecteren van auto-immuunantilichamen.
JP2002512939A (ja) 1997-11-28 2002-05-08 イノジェネティックス・ナムローゼ・フェンノートシャップ 診断および治療のためのツールとしての、リューマチ性関節炎の血清により認識されるシトルリン含有合成ペプチド
FR2773157B1 (fr) 1997-12-30 2001-10-05 Bio Merieux Epitopes peptidiques reconnus par des auto-anticorps antifilaggrine presents dans le serum des patients atteints de polyarthrite rhumatoide
WO2001022085A1 (fr) * 1999-09-17 2001-03-29 Mochida Pharmaceutical Co., Ltd. Procede de mesure fractionnel de proteine de cd14 soluble
CA2391356A1 (en) 1999-12-21 2001-06-28 Innogenetics N.V. Peptides designed for the diagnosis and treatment of rheumatoid arthritis
CN100352844C (zh) * 2001-09-25 2007-12-05 财团法人化学及血清疗法研究所 重组抗骨桥蛋白抗体及其用途
NL1019540C2 (nl) 2001-12-11 2003-07-01 Stichting Tech Wetenschapp Werkwijze voor het detecteren van auto-antilichamen van patienten die lijden aan reumatoïde artritis, peptide en assaykit.

Also Published As

Publication number Publication date
EP1721162B1 (en) 2008-09-24
ATE409314T1 (de) 2008-10-15
US7981693B2 (en) 2011-07-19
DE602005009925D1 (de) 2008-11-06
ES2314621T3 (es) 2009-03-16
JP4495208B2 (ja) 2010-06-30
US20070298518A1 (en) 2007-12-27
JP2007524100A (ja) 2007-08-23
EP1980855A1 (en) 2008-10-15
CA2552420A1 (en) 2005-09-15
EP1721162A1 (en) 2006-11-15
SI1721162T1 (sl) 2009-02-28
WO2005085858A1 (en) 2005-09-15
US8062907B2 (en) 2011-11-22
PT1721162E (pt) 2008-12-03
PL1721162T3 (pl) 2009-03-31
US20110129861A1 (en) 2011-06-02

Similar Documents

Publication Publication Date Title
DK1721162T3 (da) Fremgangsmåde til at bedömme rheumatoid arthritis ved at måle anti-CCP og serumamyloid A
CY1111229T1 (el) Μεθοδος προσδιορισμου ρευματοειδους αρθριτιδας με μετρηση αντι-ccp και ιντερλευκλινης 6
HK1149956A1 (en) Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex
ATE522812T1 (de) Verfahren und zusammensetzung zum bestimmen von homocystein
MX2007014815A (es) Metodos de inmunoanalisis mejorados.
CA2818940C (en) Method and apparatus for determination of system parameters for reducing crude unit corrosion
WO2012075076A3 (en) Method and apparatus for determination of system parameters for reducing crude unit corrosion
ATE428929T1 (de) Reagens, ausstattung und verfahren zur probenanalyse
ATE541054T1 (de) Bio-barcode erkennung für zielmoleküle
DE60330248D1 (de) Teststreifen zum analytnachweis und verwendungsverfahren
ATE503846T1 (de) Verfahren zur diagnose eines ovarialkarzinoms
TW200745551A (en) Device and methods for detecting and quantifying one or more target agents
FR2894675B1 (fr) Distinction des meningites bacteriennes et virales
HK1091540A1 (en) Use of a virus expressing a binding moiety to measure analytes in a sample
ATE524556T1 (de) Verfahren zur zyklischen nukleotid-bestimmung
EP1605260A3 (de) Verfahren und Testkit zur Bestimmung des organisch gebundenen Kohlenstoffs (TOC)
ATE412181T1 (de) Verbessertes verfahren zur diagnose des akuten koronarsyndroms
CY1109461T1 (el) Βελτιωμενες μεθοδοι ανοσολογικου προσδιορισμου
DE60121547D1 (de) Electrochemisches verfahren zum nachweis von nukleinsäuren
MX2022012840A (es) Inmunoensayo de desactivacion de fluorescencia.
GB2456690A (en) A method for quantitative detection of diabetes related immunological markers
ATE465407T1 (de) Verfahren zum spezifischen nachweis von legionella pneumophila
ATE305980T1 (de) Verwendung von abfangsonden beim nachweis von nukleinsäuren
BRPI0512611A (pt) métodos e composições para a detecção de moléculas biológicas empregando um complexo de duas partìculas